Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Dexcom

Is DexCom Stock Underperforming the Nasdaq?

Despite DexCom's lagging performance relative to the Nasdaq Composite over the past year, Wall Street analysts maintain a strong bullish outlook on the stock's prospects.

Key Takeaways From DexCom Analyst Ratings

Key Takeaways From DexCom Analyst Ratings

DexCom (NASDAQ:DXCM) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The Stelo glucose biosensor changed the way I manage my diabetes - I tested it for two weeks, and here's how it went

The Stelo glucose biosensor changed the way I manage my diabetes - I tested it for two weeks, and here's how it went

The Stelo glucose biosensor is more affordable and accessible, but how well does it work for diabetics?

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Dexcom Glucose Data To Be Integrated With ŌURA Rings

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help improve consumers' metabolic health.

International Business Times

Your Oura Ring will be able to show you glucose readings in 2025 – thanks to Dexcom integration

The company is now valued at over $5 billion

Are Wall Street Analysts Predicting DexCom Stock Will Climb or Sink?

Despite DexCom’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Nick Jonas wants to 'take bigger risks' as he reflects on 'wild' Jonas Brothers milestone

EXCLUSIVE The singer-songwriter and actor has crammed a lot into his 32 years of life and the ‘incredibly ambitious and driven’ star is determined there will be a lot more to come

Evening Standard

inkl

Read news from The Economist, FT, and more,
with one subscription

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits

Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.

The Conversation

Here's What to Expect From DexCom's Next Earnings Report

Here's What to Expect From DexCom's Next Earnings Report

DexCom is poised to announce its third-quarter results later this month, with analysts predicting a double-digit decline in the company's earnings.

Is DexCom Stock Underperforming the S&P 500?

Is DexCom Stock Underperforming the S&P 500?

Despite DexCom’s underperformance compared to the S&P 500 Index over the past year, Wall Street analysts are highly bullish about the stock’s prospects.

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation

Is Wall Street Bullish or Bearish on DexCom Stock?

Is Wall Street Bullish or Bearish on DexCom Stock?

Despite DexCom lagging behind the broader market over the past year, Wall Street analysts remain bullish on the stock’s prospects.

Stock Market Today: Dow Adds 654 Points as 3M Stock Explodes Higher

Stock Market Today: Dow Adds 654 Points as 3M Stock Explodes Higher

It was a risk-on day for stocks thanks to an upbeat inflation reading and impressive earnings from 3M and Deckers.

Dexcom Stock Sinks on Sales Miss, Guidance Cut: What to Know

Dexcom Stock Sinks on Sales Miss, Guidance Cut: What to Know

Dexcom stock is crashing Friday after the glucose monitoring company reported dismal Q2 revenue and slashed its full-year sales guidance. Here's what you need to know.

Get all your
news in one place.

100’s of premium titles.
One news app.

3 Top-Rated Healthcare Stocks With 20% to 35% Upside Potential

Amid a broader market rotation out of Big Tech stocks, investors can consider these three top-rated healthcare stocks with double-digit upside potential.

Your Apple Watch can track blood sugar levels — here's how with Dexcom G7

Learn to set up and use the Dexcom G7 CGM system with your Apple Watch for convenient, real-time blood sugar monitoring.

Earnings Preview: What to Expect From DexCom's Report

DexCom is gearing up to announce its second-quarter results this month, and analysts are anticipating a double-digit increase in the company’s bottom-line figure.

How Is DexCom's Stock Performance Compared to Other Medical Devices Stocks?

Despite DexCom’s underperformance compared to its industry, Wall Street analysts remain optimistic about the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is poised for tremendous growth driven by the aging population and rising incidence of chronic diseases. Hence, quality healthcare stocks, Danaher (DHR), Amgen (AMGN), and DexCom (DXCM), benefiting from an aging population, might be worth looking into. Read more….

Evening Standard

'I'm on my own a lot': Roxy Horner on raising daughter as fiancé Jack Whitehall works abroad

EXCLUSIVE The model says she achieved a long-time dream when she welcomed Elsie in September 2023 with her comedian partner

Evening Standard

Roxy Horner worries she's a 'burden' to fiancé Jack Whitehall because of diabetes diagnosis

EXCLUSIVE The model fears their daughter could inherit the condition, which she says is ‘serious’ but ‘liveable’

Dexcom's blood sugar monitors now sync directly with your Apple Watch — here's why it's a big deal

The Dexcom G7 blood glucose monitor can now sync directly with Apple Watch for faster readings — no iPhone required.

Your Apple Watch can now track your real-time blood sugar... sort of – here's how

One popular blood sugar tracker for the iPhone has released an update that lets readings get sent straight to your Apple Watch, letting you track straight from your wrist.

The Apple Watch will now connect to a Dexcom glucose monitor in your arm

Dexcom's latest update for the G7 continuous glucose monitor lets it connect to the Apple Watch for real-time readings – no iPhone needed.

Strong Tech Earnings Boost Stocks

The S&P 500 Index ($SPX ) (SPY ) Friday closed up +1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.65%. US stock indexes rallied Friday, with the S&P 500 posting a 1-1/2 week high...

People

Priyanka Chopra

The Jonas Brothers

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

Dow Jones Industrials

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

344,910 stories

Aotearoa New Zealand

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play